Future Medicine Co., Ltd. (XKON: 341170)
1,900.00
0.00 (0.00%)
At close: Sep 10, 2024
Future Medicine Company Description
Future Medicine Co., Ltd. operates as a drug development company worldwide.
It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy.
The company was founded in 2015 and is based in Seongnam, South Korea.
Future Medicine Co., Ltd.
Country | South Korea |
Founded | 2015 |
Industry | Pharmaceutical Preparations |
Contact Details
Address: Rm 616 LH-Business Growth Center Seongnam, 13449 South Korea | |
Phone | 82 2 3429 3473 |
Website | futuremedicine.co.kr |
Stock Details
Ticker Symbol | 341170 |
Exchange | Korea New Exchange |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2834 |